SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026)
SELLAS Life Sciences (SLS) reported Treasury Shares of $3.8 million for Q3 2017, little changed year-over-year from $3.8 million in Q3 2016, and little changed on a QoQ basis from $3.8 million in Q2 2017.
SELLAS Life Sciences (SLS) has 8 years of Treasury Shares data on file, last reported at $3.8 million in Q3 2017.
- Quarterly Treasury Shares changed 0.0% year-over-year to $3.8 million in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $3.8 million (changed 0.0% YoY) and the FY2016 annual result came in at $3.8 million, changed 0.0% from the prior year.
- Treasury Shares held at $3.8 million in Q3 2017 per SLS's latest filing, from $3.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.3 million in Q1 2026 and bottomed at $255000.0 in Q4 2022.
- The 5-year median for Treasury Shares is $472000.0 (2024), against an average of $799411.8.
- Peak annual rise in Treasury Shares reached 0.0% in 2013, while the deepest fall reached 0.0% in 2013.
- Tracing SLS's Treasury Shares over 5 years: stood at $3.8 million in 2013, then changed by 0.0% to $3.8 million in 2014, then changed by 0.0% to $3.8 million in 2015, then changed by 0.0% to $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017.
- Per Business Quant, the three latest SLS Treasury Shares figures stand at $3.8 million (Q3 2017), $3.8 million (Q2 2017), and $3.8 million (Q1 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 897,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 472,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Dec 31, 2023 | 338,000.00 |
| Dec 31, 2023 | 338,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 444,000.00 |
| Mar 31, 2023 | 444,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 297,000.00 |
| Sep 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 297,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Dec 31, 2020 | 170,000.00 |
| Dec 31, 2020 | 170,000.00 |
| Sep 30, 2020 | 170,000.00 |
| Sep 30, 2020 | 170,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Mar 31, 2020 | 170,000.00 |
| Mar 31, 2020 | 170,000.00 |
| Sep 30, 2019 | 230.00 |
| Sep 30, 2019 | 230.00 |
| Jun 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 13,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Dec 31, 2018 | 13,000.00 |
| Dec 31, 2018 | 13,000.00 |
| Sep 30, 2018 | 13,000.00 |
| Sep 30, 2018 | 13,000.00 |
| Jun 30, 2018 | 13,000.00 |
| Jun 30, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Dec 31, 2017 | 13,000.00 |
| Dec 31, 2017 | 13,000.00 |
| Sep 30, 2017 | 3.85 Mn |
| Sep 30, 2017 | 33,750.00 |
| Sep 30, 2017 | 3.85 Mn |
| Sep 30, 2017 | 33,750.00 |
| Jun 30, 2017 | 33,750.00 |
| Jun 30, 2017 | 3.85 Mn |
| Jun 30, 2017 | 3.85 Mn |
| Jun 30, 2017 | 33,750.00 |
| Mar 31, 2017 | 675,000.00 |
| Mar 31, 2017 | 675,000.00 |
| Mar 31, 2017 | 3.85 Mn |
| Mar 31, 2017 | 3.85 Mn |
| Dec 31, 2016 | 3.85 Mn |
| Dec 31, 2016 | 3.85 Mn |
| Dec 31, 2016 | 21,000.00 |
| Dec 31, 2016 | 21,000.00 |
| Sep 30, 2016 | 675,000.00 |
| Sep 30, 2016 | 675,000.00 |
| Sep 30, 2016 | 3.85 Mn |
| Sep 30, 2016 | 3.85 Mn |
| Jun 30, 2016 | 675,000.00 |
| Jun 30, 2016 | 3.85 Mn |
| Jun 30, 2016 | 3.85 Mn |
| Jun 30, 2016 | 675,000.00 |
| Mar 31, 2016 | 3.85 Mn |
| Mar 31, 2016 | 675,000.00 |
| Mar 31, 2016 | 675,000.00 |
| Mar 31, 2016 | 3.85 Mn |
| Dec 31, 2015 | 33,750.00 |
| Dec 31, 2015 | 3.85 Mn |
| Dec 31, 2015 | 3.85 Mn |
| Dec 31, 2015 | 33,750.00 |
| Sep 30, 2015 | 3.85 Mn |
| Sep 30, 2015 | 675,000.00 |
| Sep 30, 2015 | 675,000.00 |
| Sep 30, 2015 | 3.85 Mn |
| Jun 30, 2015 | 675,000.00 |
| Jun 30, 2015 | 3.85 Mn |
| Jun 30, 2015 | 3.85 Mn |
| Jun 30, 2015 | 675,000.00 |
| Mar 31, 2015 | 3.85 Mn |
| Mar 31, 2015 | 675,000.00 |
| Mar 31, 2015 | 675,000.00 |
| Mar 31, 2015 | 3.85 Mn |
| Dec 31, 2014 | 3.85 Mn |
| Dec 31, 2014 | 3.85 Mn |
| Dec 31, 2014 | 675,000.00 |
| Dec 31, 2014 | 675,000.00 |
| Sep 30, 2014 | 3.85 Mn |
| Sep 30, 2014 | 675,000.00 |
| Sep 30, 2014 | 675,000.00 |
| Sep 30, 2014 | 3.85 Mn |
| Jun 30, 2014 | 3.85 Mn |
| Jun 30, 2014 | 3.85 Mn |
| Jun 30, 2014 | 675,000.00 |
| Jun 30, 2014 | 675,000.00 |
| Mar 31, 2014 | 675,000.00 |
| Mar 31, 2014 | 675,000.00 |
| Mar 31, 2014 | 3.85 Mn |
| Mar 31, 2014 | 3.85 Mn |
| Dec 31, 2013 | 675,000.00 |
| Dec 31, 2013 | 3.85 Mn |
| Dec 31, 2013 | 3.85 Mn |
| Dec 31, 2013 | 675,000.00 |
| Sep 30, 2013 | 3.85 Mn |
| Sep 30, 2013 | 675,000.00 |
| Sep 30, 2013 | 675,000.00 |
| Sep 30, 2013 | 3.85 Mn |
| Jun 30, 2013 | 675,000.00 |
| Jun 30, 2013 | 675,000.00 |
| Jun 30, 2013 | 3.85 Mn |
| Jun 30, 2013 | 3.85 Mn |
| Mar 31, 2013 | 3.85 Mn |
| Mar 31, 2013 | 675,000.00 |
| Mar 31, 2013 | 675,000.00 |
| Mar 31, 2013 | 3.85 Mn |
| Dec 31, 2012 | 675,000.00 |
| Dec 31, 2012 | 3.85 Mn |
| Dec 31, 2012 | 675,000.00 |
| Dec 31, 2012 | 3.85 Mn |
| Sep 30, 2012 | 3.85 Mn |
| Sep 30, 2012 | 675,000.00 |
| Sep 30, 2012 | 675,000.00 |
| Sep 30, 2012 | 3.85 Mn |
| Jun 30, 2012 | 675,000.00 |
| Jun 30, 2012 | 675,000.00 |
| Mar 31, 2012 | 675,000.00 |
| Mar 31, 2012 | 3.85 Mn |
| Mar 31, 2012 | 675,000.00 |
| Mar 31, 2012 | 3.85 Mn |
| Dec 31, 2011 | 675,000.00 |
| Dec 31, 2011 | 675,000.00 |
| Dec 31, 2011 | 3.85 Mn |
| Dec 31, 2011 | 3.85 Mn |
| Sep 30, 2011 | 3.85 Mn |
| Sep 30, 2011 | 675,000.00 |
| Sep 30, 2011 | 3.85 Mn |
| Sep 30, 2011 | 675,000.00 |
| Jun 30, 2011 | 3.85 Mn |
| Jun 30, 2011 | 675,000.00 |
| Jun 30, 2011 | 675,000.00 |
| Jun 30, 2011 | 3.85 Mn |
| Dec 31, 2010 | 675,000.00 |
| Dec 31, 2010 | 3.85 Mn |
| Dec 31, 2010 | 3.85 Mn |
| Dec 31, 2010 | 675,000.00 |